Huons
8th Floor HuonsGlobal Bldg., A-dong Pangyo I-Square, 17, Changeop-ro, Seongnam-si, Gyeonggi-do, 13449, Republic of Korea
Overview
Huons has manufactured the high quality finished products since 1965 and developed first local anesthetics and plastic ampoule injection in Korea. they are doing their best to supply high quality products through strict quality control system and continued R&D efforts based on the technologies and know-how accumulated. Huons has been exporting their finished pharmaceutical products to about 30 countries including N/S.America, Europe, Japan, Asia, and Africa.
- Total investments
- 2
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Health Care
- Manufacturing
- Pharmaceutical
Investment portfolio
- PharmCADD
Led · Series B · Apr 2021
PharmCADD develops an AI- and physics-based drug discovery platform called Pharmulator™, which integrates protein 3D structure prediction, molecular dynamics, quantum calculation, toxicity prediction and AI drug generation. The platform is used to generate novel synthetic small molecules and to support work in PROTACs, mRNA vaccines and drug delivery systems. PharmCADD reports a co-developed mRNA COVID-19 vaccine with Eyegene that demonstrated neutral antibody titers similar to the Moderna vaccine. The company employs about 50 people, including 34 R&D staff and 17 Ph.D.s. The Series B proceeds will be used to advance Pharmulator™, expand R&D headcount, and fund preclinical studies of internal pipelines. PharmCADD also plans to expand internationally by launching U.S. and India branches.
- Master Meditech
Participated · Series A · Mar 2021
Master Meditech Inc. announced a KRW 8 billion Series A funding round closed on March 29, 2021. The articles report participation from a mix of corporate and investment firms. Named participants include Samho Green Investment, Paratus Investment (and a Paratus‑managed fund, CP Partners LLC), Spring Camp, Huons Co., Pharmbio Co., INNOCENCE Co.Ltd, King Mind Partners, and Foresite‑Cape Bio New Technology Investment Association. The coverage does not disclose valuation, use of proceeds, revenue, or user metrics. No founding year or company location is provided in the articles.
Team
No current team members are available.